David Weinstock, Senior Vice President at Roche, shared a post on LinkedIn:
“I am thrilled to join Roche as Head of the Oncology Disease Translational Area (DTA) in Pharma Research and Early Development (pRED) in Basel, Switzerland.
Roche’s commitment to turning science into breakthroughs is inspiring. The opportunities to transform the lives of people with cancer have never been greater. I’m humbled to lead an incredible team of scientists and clinicians, working closely with our colleagues across Roche, Genentech, and Chugai Pharmaceutical, to discover, innovate, and develop the next generation of cancer therapies.”
More posts featuring Roche.